VoICE Immunization Evidence

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children

Authored by: Madhi, S.A., Kuwanda, L., Cutland, C., et al

Appears in:

Key Idea

Key Evidence: A large randomized controlled trial of a pneumococcal conjugate vaccine in South Africa found that use of the vaccine prevented 10 times as many cases of pneumococcal pneumonia in HIV positive children than in HIV negative children.

Published In

Madhi, S.A., Kuwanda, L., Cutland, C., et al 2005. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clinical Infectious Disease. 40:1511-8.